It's not a one-size-fits-all solution, and it's certainly not a magic bullet
As a surgeon, I recommend focusing on evidence-based recovery protocols , including: High-quality nutrition (protein, collagen, vitamin C, etc.) Guided physical therapy Avoiding smoking or nicotine Gradual, personalized rehabilitation programs Until peptide therapies are better studied in humans, they should not replace established recovery strategies
Pharmacy staff should advise patients to keep a diary of their symptoms and to speak to their GP about any potential change to their treatment schedule
Some suggest splitting doses, others insist on single morning administration
Retatrutide (CAS 2381089-83-2) is a triple-agonist peptide that engages three receptors simultaneously the glucose-dependent insulinotropic polypeptide (GIP) receptor, the glucagon-like peptide-1 (GLP-1) receptor, and the glucagon receptor making it one of the most-studied multi-receptor metabolic peptides currently in the research literature